We studied the kinetics of exogenous recombinant 22-kDa human growth hormon
e (rhGH) in premenopausal women with upper body obesity (UBO), lower body o
besity (LBO), or normal body weight. A bolus of 100 mU rhGH was administere
d during a continuous infusion of somatostatin to suppress endogenous GH se
cretion. GH kinetics were investigated with noncompartmental analysis of pl
asma GH curves. GH peak values in response to GH infusion and plasma half-l
ife of GH were not significantly different between normal weight and obese
subjects. In contrast, GH clearance was 33% higher in LBO women and 51% hig
her in UBO women compared with clearance in normal weight controls. The dif
ference in clearance between LBO and UBO was not statistically significant.
Altered GH clearance characteristics contribute to low circulating GH leve
ls in obese humans. Body fat distribution does not appear to affect GH kine
tics.